ESC 365 - The role of drug therapy in atrial fibrillation patients with heart failure and preserved left ventricular ejection fraction

ESC Professional Premium Access

The role of drug therapy in atrial fibrillation patients with heart failure and preserved left ventricular ejection fraction

Session: Treatment options for patients with atrial fibrillation and heart failure with preserved left ventricular function

Topic: Atrial Fibrillation (AF)

Speaker: Doctor R. Zakeri (London, GB)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Rosita Zakeri

King's College London, London (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

3 more presentations in this session

The role of catheter ablation for atrial fibrillation in atrial fibrillation patients with heart failure and preserved left ventricular ejection fraction

Speaker: Professor P. Sommer (Bad Oeynhausen, DE)

The role of AV nodal ablation and physiological pacing in atrial fibrillation patients with heart failure and preserved left ventricular ejection fraction

Speaker: Professor M. Brignole (Milan, IT)

Treatment options for patients with atrial fibrillation and heart failure with preserved left ventricular function - discussion

Access the full session

Treatment options for patients with atrial fibrillation and heart failure with preserved left ventricular function

Speakers: Doctor R. Zakeri, Professor P. Sommer, Professor M. Brignole

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources